Pyrosequencing Dried Blood Spots Reveals Differences in HIV Drug Resistance between Treatment Naïve and Experienced Patients

• Hezhao Ji,

  Affiliation National HIV & Retrovirology Laboratories, National Microbiology Laboratory, Public Health Agency of Canada, Ottawa, Canada

  ⨯
• Yang Li,

  Affiliation National HIV & Retrovirology Laboratories, National Microbiology Laboratory, Public Health Agency of Canada, Ottawa, Canada

  ⨯
• Binhua Liang,

  Affiliations Bioinformatics Core, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada, Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada

  ⨯
• Richard Pilon,

  Affiliation National HIV & Retrovirology Laboratories, National Microbiology Laboratory, Public Health Agency of Canada, Ottawa, Canada

  ⨯
• Paul MacPherson,

  Affiliation Division of Infectious Diseases, The Ottawa Hospital, Ottawa, Canada

  ⨯
• Michèle Bergeron,

  Affiliation National HIV & Retrovirology Laboratories, National Microbiology Laboratory, Public Health Agency of Canada, Ottawa, Canada

  ⨯
• John Kim,

  Affiliation National HIV & Retrovirology Laboratories, National Microbiology Laboratory, Public Health Agency of Canada, Ottawa, Canada

  ⨯
• Morag Graham,

  Affiliations Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada, Genomics Core Facility, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada

  ⨯
• Gary Van Domselaar,

  Affiliation Bioinformatics Core, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada

  ⨯
• Paul Sandstrom,

  Affiliation National HIV & Retrovirology Laboratories, National Microbiology Laboratory, Public Health Agency of Canada, Ottawa, Canada

  ⨯
• James Brooks

  * E-mail: james_brooks@phac-aspc.gc.ca

  Affiliation National HIV & Retrovirology Laboratories, National Microbiology Laboratory, Public Health Agency of Canada, Ottawa, Canada

  ⨯